Orca-T

N/A

Report date: 2025/10/11 17:38:37

Base Information

Drug NameOrca-T
Drug Alias NameOrca-TTregGraftTregCD34TRGFT-201
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsBlastic Plasmacytoid Dendritic Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative Diseases +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesOrca Biosystems IncStanford University
China Registration ClassN/A

Develop Information

Active CompaniesStanford UniversityNational Cancer InstituteOrca Biosystems Inc
Inactive CompaniesN/A
Active IndicationsBlastic Plasmacytoid Dendritic Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative Diseases +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A